Cargando…
Ameliorative Effects Of N-Acetylcysteine As Adjunct Therapy On Symptoms Of Painful Diabetic Neuropathy
PURPOSE: Painful diabetic neuropathy (PDN) is a variant of diabetic peripheral neuropathy which is highly prevalent and distressing in diabetic patients. Despite its high burden, the optimal treatment of PDN has remained a clinical challenge. To explain the emergence and maintenance of PDN, increasi...
Autores principales: | Heidari, Narges, Sajedi, Firozeh, Mohammadi, Younes, Mirjalili, Mahtabalsadat, Mehrpooya, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875491/ https://www.ncbi.nlm.nih.gov/pubmed/31819599 http://dx.doi.org/10.2147/JPR.S228255 |
Ejemplares similares
-
Evidence for a Beneficial Effect of Oral N-acetylcysteine on Functional Outcomes and Inflammatory Biomarkers in Patients with Acute Ischemic Stroke
por: Sabetghadam, Maryam, et al.
Publicado: (2020) -
N-acetylcysteine as an adjunct treatment of schizophrenia
por: Freitas, R. Mota, et al.
Publicado: (2021) -
N-Acetylcysteine causes analgesia in a mouse model of painful
diabetic neuropathy
por: Notartomaso, Serena, et al.
Publicado: (2020) -
Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophrenia
por: Willborn, Robert J., et al.
Publicado: (2019) -
N-acetylcysteine as an adjunctive treatment for smoking cessation: a randomized clinical trial
por: Machado, Regina C.B.R., et al.
Publicado: (2020)